Jazz Pharmaceuticals (JAZZ) Divestments (2015)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Divestments of $1.0 million in Q2 2015, down 96.97% quarter-over-quarter from $33.0 million in Q1 2015.
Jazz Pharmaceuticals (JAZZ) Divestments (2015) Analysis & Trends
Jazz Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2015.
- In Q2 2015, Divestments changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2016 stood at $1.0 million (down 96.97% YoY), while the FY2022 annual figure was $53.0 million, changed N/A from the prior year.
- Divestments was $1.0 million for Q2 2015 at Jazz Pharmaceuticals, down from $33.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $33.0 million in Q1 2015 to a low of $1.0 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.00 Mn |
| Mar 31, 2015 | 33.00 Mn |